KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomarin Pharmaceutical (BMRN) Tax Rate (2017 - 2025)

Biomarin Pharmaceutical (BMRN) has disclosed Tax Rate for 16 consecutive years, with 71.52% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Tax Rate fell 9787.0% year-over-year to 71.52%, compared with a TTM value of 27.69% through Dec 2025, up 648.0%, and an annual FY2025 reading of 27.69%, up 648.0% over the prior year.
  • Tax Rate was 71.52% for Q4 2025 at Biomarin Pharmaceutical, down from 16.79% in the prior quarter.
  • Across five years, Tax Rate topped out at 98.58% in Q4 2022 and bottomed at 249.37% in Q3 2022.
  • Average Tax Rate over 5 years is 0.59%, with a median of 17.44% recorded in 2024.
  • The sharpest move saw Tax Rate tumbled -136108bps in 2021, then soared 25247bps in 2023.
  • Year by year, Tax Rate stood at 13.03% in 2021, then soared by 656bps to 98.58% in 2022, then tumbled by -106bps to 5.42% in 2023, then skyrocketed by 586bps to 26.35% in 2024, then crashed by -371bps to 71.52% in 2025.
  • Business Quant data shows Tax Rate for BMRN at 71.52% in Q4 2025, 16.79% in Q3 2025, and 19.25% in Q2 2025.